News

Biochemistry researcher celebrates double success 30 July 2015 Bristol Biochemistry researcher Dr Sara Alvira de Celis has recently been recognised with not just one but two esteemed awards.
  • Biochemistry researcher celebrates double success 30 July 2015 Bristol Biochemistry researcher Dr Sara Alvira de Celis has recently been recognised with not just one but two esteemed awards.
  • Congratulations to our Students! 22 July 2015 The School is delighted to congratulate its undergraduate students from all years on an excellent set of examination results, perpetuating the strength and reputation of the Bristol Biochemistry degree programmes.
  • Nature study adds new evidence linking brain mutation to autism, epilepsy and other neuro disorders 17 July 2015 Findings, published on the 15th July in Nature Communications, reveal the extent a mutation associated with autism and epilepsy plays in impairing a biochemical process in the brain. The study, led by University of Bristol researchers, could provide a new target for treating neurological disorders.
  • Ultrasound accelerates skin healing – especially for diabetics and the elderly 15 July 2015 Healing times for skin ulcers and bedsores can be reduced by a third with the use of low-intensity ultrasound, scientists from the Universities of Sheffield and Bristol have found.
  • Cancer surgery or biopsy collection could influence disease progression 2 July 2015 Scientists at Bristol Biochemistry studying the body’s inflammatory response to wounds following cancer surgery or biopsy have found that these procedures may cause growth signals to be delivered to any remaining cancer or pre-cancerous cells which may negatively influence disease progression.
  • Bristol Biochemistry Academic Scoops Two Teaching Awards 26 June 2015 The winners of the 2015 Bristol Teaching Awards have been announced on Monday 15th June. The Bristol Teaching Awards are a joint venture between the University of Bristol and Bristol SU (the Students’ Union). The Awards are to recognise the most outstanding members of staff who have delivered exceptional contributions to teaching and supporting students.
  • Human trials of manufactured blood within two years 25 June 2015 The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant. Research led by scientists at the University of Bristol and NHS Blood and Transplant, used stem cells from adult and umbilical cord blood to create a small volume of manufactured red blood cells.
  • ESCRT-III controls nuclear envelope reformation 4 June 2015 Mitosis is the process by which eukaryotic cells divide up their chromosomes and form two genetically identical daughter cells. It involves a series of highly co-ordinated steps mediated by a plethora of proteins. During the final stages of mitosis (telophase) the nuclear envelope reassembles around the segregated chromosomes in a two-step process first involving the coating of chromatin by membranes from the endoplasmic reticulum followed by annular fusion of these membranes together to create a sealed barrier. Staff and Facilities of the School of Biochemistry collaborated with King's College London to investigate this, culminating in a publication in Nature.
  • Molecular basis of rapamycin insensitivity of Target Of Rapamycin Complex 2 revealed 1 June 2015 In eukaryotes, cell growth and division is stimulated by the availability of nutrients, presence of growth factors and of other cells. One of the key factors controlling cell growths is Target Of Rapamycin (TOR), a conserved, atypical protein kinase which is an important cancer therapeutic target and which is inhibited by the immunosuppressive, anti-proliferative drug rapamycin in complex with the FKBP12 protein. Decreased TOR activity has been found to increase life span in S. cerevisiae, C. elegans and mice. TOR kinase is part of two very large multi-protein complexes: rapamycin-sensitive TOR complex 1 (TORC1) and rapamycin-insensitive TOR complex 2 (TORC2). Why TORC2 is insensitive to rapamycin has been a longstanding mystery in the TOR field. In a paper published by Molecular Cell, this essential question has now been answered.
  • Bristol Biochemistry receives Athena SWAN Bronze Award 15 May 2015
Years iterator 201820172016201520142013
View all news